Form and flexibility in phosphoinositide 3-kinases

被引:77
作者
Williams, Roger [1 ]
Berndt, Alex [1 ]
Miller, Simon [1 ]
Hon, Wai-Ching [1 ]
Zhang, Xuxiao [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
cancer; p85; p110; phosphoinositide 3-kinase (P13K); phosphoinositide 3,4,5-trisphosphate; G-BETA-GAMMA; CANCER-SPECIFIC MUTATIONS; LIPID KINASE-ACTIVITY; CLASS-IA PI3K; PHOSPHATIDYLINOSITOL; 3-KINASE; REGULATORY SUBUNIT; CELL-MIGRATION; HEART-FAILURE; ONCOGENIC TRANSFORMATION; DEPENDENT MECHANISM;
D O I
10.1042/BST0370615
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
P13Ks (phosphoinositide 3-kinases) have important roles in a variety of cellular activities, including survival, proliferation, growth, shape, migration and intracellular sorting. Consistent with their function in cell survival and growth, the gene for the class l alpha P13K catalytic subunit is a common site of gain-of-function mutations in cancers. Ongoing structural studies of these enzymes and the complexes they make with their regulatory subunits have helped to clarify the mechanistic basis of this role in tumour development. The broad spectrum of biological activities associated with various isotypes of class I P13Ks has led to an intense search for isotype-specific inhibitors as tools in mammalian cell biology and for therapeutic application. Structural studies of the class I P13Ks suggest that flexibility may be a component of the catalytic cycle of the enzymes.
引用
收藏
页码:615 / 626
页数:12
相关论文
共 110 条
[1]
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases [J].
Apsel, Beth ;
Blair, Jimmy A. ;
Gonzalez, Beatriz ;
Nazif, Tamim M. ;
Feldman, Morri E. ;
Aizenstein, Brian ;
Hoffman, Randy ;
Williams, Roger L. ;
Shokat, Kevan M. ;
Knight, Zachary A. .
NATURE CHEMICAL BIOLOGY, 2008, 4 (11) :691-699
[2]
The PIK3CA gene is mutated with high frequency in human breast cancers [J].
Bachman, KE ;
Argani, P ;
Samuels, Y ;
Silliman, N ;
Ptak, J ;
Szabo, S ;
Konishi, H ;
Karakas, B ;
Blair, BG ;
Lin, C ;
Peters, BA ;
Velculescu, VE ;
Park, BH .
CANCER BIOLOGY & THERAPY, 2004, 3 (08) :772-775
[3]
The regulation and function of Class III PI3Ks: novel roles for Vps34 [J].
Backer, Jonathan M. .
BIOCHEMICAL JOURNAL, 2008, 410 (01) :1-17
[4]
Cancer-specific mutations in PIK3CA are oncogenic in vivo [J].
Bader, AG ;
Kang, SY ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) :1475-1479
[5]
PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus [J].
Barber, DF ;
Bartolomé, A ;
Hernandez, C ;
Flores, JM ;
Redondo, C ;
Fernandez-Arias, C ;
Camps, M ;
Ruckle, T ;
Schwarz, MK ;
Rodríguez, S ;
Martinez-A, C ;
Balomenos, D ;
Rommel, C ;
Carrera, AC .
NATURE MEDICINE, 2005, 11 (09) :933-935
[6]
Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Nussbaum, RL .
MAMMALIAN GENOME, 2002, 13 (03) :169-172
[7]
A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16 [J].
Billottet, C. ;
Grandage, V. L. ;
Gale, R. E. ;
Quattropani, A. ;
Rommel, C. ;
Vanhaesebroeck, B. ;
Khwaja, A. .
ONCOGENE, 2006, 25 (50) :6648-6659
[8]
Bifurcation of lipid and protein kinase signals of PI3Kγ to the protein kinases PKB and MAPK [J].
Bondeva, T ;
Pirola, L ;
Bulgarelli-Leva, G ;
Rubio, I ;
Wetzker, R ;
Wymann, MP .
SCIENCE, 1998, 282 (5387) :293-296
[9]
Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ [J].
Brock, C ;
Schaefer, M ;
Reusch, HP ;
Czupalla, C ;
Michalke, M ;
Spicher, K ;
Schultz, G ;
Nürnberg, B .
JOURNAL OF CELL BIOLOGY, 2003, 160 (01) :89-99
[10]
Insulin activates the α isoform of class II phosphoinositide 3-kinase [J].
Brown, RA ;
Domino, J ;
Arcaro, A ;
Waterfield, MD ;
Shepherd, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :14529-14532